# Zura Bio (ZURA) — Analyst Forecast

ZURA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/zura/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 12, 2026 | Guggenheim | Maintained | Buy | $20.00 |
| Aug 12, 2026 | Wedbush | Maintained | Outperform | $22.00 |
| Jul 8, 2026 | William Blair | Initiated Coverage | Outperform | — |
| Jul 1, 2026 | Wedbush | Maintained | Outperform | $15.00 |
| Mar 23, 2026 | Chardan Capital | Maintained | Buy | $11.00 |
| Mar 20, 2026 | Oppenheimer | Maintained | Outperform | $15.00 |
| Feb 9, 2026 | Wedbush | Initiated Coverage | Outperform | $15.00 |
| Nov 14, 2025 | Chardan Capital | Maintained | Buy | $10.00 |
| Nov 13, 2025 | Clear Street | Initiated Coverage | Buy | $18.00 |
| Sep 30, 2025 | Chardan Capital | Maintained | Buy | $10.00 |
| Aug 19, 2025 | HC Wainwright & Co. | Maintained | Neutral | $2.00 |
| Aug 15, 2025 | Chardan Capital | Maintained | Buy | $10.00 |
| Aug 15, 2025 | Oppenheimer | Maintained | Outperform | $16.00 |
| May 9, 2025 | Oppenheimer | Maintained | Outperform | $17.00 |
| Apr 3, 2025 | HC Wainwright & Co. | Maintained | Neutral | $3.00 |
| Mar 26, 2025 | Chardan Capital | Maintained | Buy | $10.00 |
| Mar 26, 2025 | Guggenheim | Maintained | Buy | $15.00 |
| Mar 26, 2025 | Oppenheimer | Maintained | Outperform | $19.00 |
| Dec 24, 2024 | HC Wainwright & Co. | Maintained | Neutral | $5.00 |
| Dec 11, 2024 | Cantor Fitzgerald | Maintained | Overweight | — |

## Frequently Asked Questions

### Is ZURA a buy, sell, or hold?

Analysts covering Zura Bio currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on ZURA?

On Aug 12, 2026, Guggenheim maintained Zura Bio at Buy with a price target of $20.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).